Blog

Today's video focuses on Advanced Micro Devices' (NASDAQ:AMD) recent earnings reported on Oct. 26, after the market closed. Here are some highlights from the video. 

Click the video below for my

It's hard to believe that 2021 is almost over. While no one knows what's in store for the stock market in 2022, the end of the year is always a good time to check that your investments are anchored

Johnson & Johnson (NYSE: JNJ) has faced its fair share of consumer lawsuits in its company history and paid out billions of dollars in settlements over the years. In this segment of Backstage Pass

It's no secret that the stock market is prone to volatility, and it can be intimidating to invest when a market downturn could be just around the corner.

While some investors believe a market crash

Six years ago, JD.com (NASDAQ: JD), China's largest direct retailer, invested about $50 million in a U.S. e-commerce start-up. That start-up was ContextLogic's (NASDAQ: WISH) Wish, which eventually

Earnings season always garners the attention of investors and can lead to significant shifts in a company's stock. With that season currently upon us a lot of organizations are finding themselves as

The healthcare industry is known to be financially resilient -- companies in it provide products and services that people will continue to need regardless of outside factors such as changes in the

With a return of 2,400% since its 2016 IPO, advertising technology company The Trade Desk (NASDAQ: TTD) has been an incredible performer for early investors, but it has captured a surprisingly small

Cannabis producer Canopy Growth (NASDAQ: CGC) has always been one of the more aggressive companies in Canada with respect to U.S. expansion efforts. A few years ago, it made headlines when it

If you're a cannabis investor, then you're probably familiar with the top stocks in the sector, such as Aurora Cannabis, Trulieve Cannabis, and Curaleaf Holdings. These stocks have large followings

What does an aging U.S. population have to do with investing? In this segment of Backstage Pass, recorded on Oct. 13, Fool contributors Brian Withers, Rachel Warren, and Trevor Jennewine discuss one

The group of technologies that enable gene editing help scientists modify an organism's DNA. This field is very promising since it could help unlock successful and innovative therapies for various

The benchmark S&P 500 index is back at all-time highs after a paltry 5% dip during the September and October market sell-off. Investors who were hoping for a more attractive buying opportunity might

Fintech-giant Square (NYSE: SQ) has been quite the impressive growth story. Over the years, the company has evolved from a niche payment processor into a full-featured financial ecosystem, and early

In 2022, the maximum Social Security benefit will be $4,194 per month. Most people won't get anywhere near maxing out their benefits, though. 

If you're still working and you're hoping to get the

No one likes inflation. Investors are naturally concerned about safeguarding their portfolio when inflation is high. Rather than waiting for inflation to simmer down before buying more stocks

COVID-19 vaccine maker Novavax (NASDAQ: NVAX) has been a volatile stock to own over the past year. Although its shares are up over 60% during the past 12 months (beating the S&P 500 and its 36%

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) expect their COVID-19 vaccine will generate sales of $33.5 billion this year. Moderna (NASDAQ: MRNA) anticipates sales of around $20 billion this year

Last week, the world's largest audio platform, Spotify (NYSE: SPOT), announced that it is rolling out the ability for podcast creators to include videos in their shows. Though Spotify has long been

If you're like most investors, the mere mention of the words "stock market crash" is unnerving. That's because the downside we witness during steep corrections often occurs in a short time frame.

A 2021 survey by Natixis Investment Managers concludes that 42% of savers worry they won't have the option to retire. Notably, the group behind that percentage includes retirement savers with

Which companies of today will stand the test of time? There's a pretty good chance the list will include several big drugmakers. They're able to invest billions of dollars in the research and

Investors are worried about spiking inflation and what it could mean for the economy as well as the stock market. In the following segment of Backstage Pass, recorded on Oct. 13, Fool contributors

When it comes to market value, Regeneron Pharmaceuticals (NASDAQ: REGN) may look like small potatoes compared to Amazon. The biotech company's market capitalization totals $61 billion. The

Facebook (NASDAQ: FB) and Intuitive Surgical (NASDAQ: ISRG) aren't two stocks you'll see mentioned together very often, if at all. They have practically nothing in common. Facebook is a social-media